AREV Brands International Ltd. (CSE: AREV) (OTC: AREVF), is pleased to announce that it has contributed DNA samples from select BC Bud Depot genovarsTM to the inaugural batch run on the world’s first BeadArray genotype chip to be designed specifically for the cannabis genome. The Illumina Infinium HTS microarray, designed and wholly owned by C […]

MediPharm Labs Corp. (OTCQX: MEDIF) (TSX-V: LABS) (FSE: MLZ) announced that the Company has qualified to trade on the OTCQX® Best Market. MediPharm Labs upgraded to OTCQX from the OTCQB® Venture Market and begins trading under the symbol “MEDIF”. MediPharm Labs Corp. announced the appointment of Dr. Paul Tam, MBBS, FRCP(C), FACP to its Board […]

Pioneer Cannabis Corp. (“Pioneer Cannabis”), a national cannabis retail service provider, is pleased to announce it has signed a Master Cannabis Retail and Licensing Agreement (“Licensing Agreement”) with Ontario cannabis retail lottery winner Guruveer Sangha who will be the owner and operator of the first Pioneer Cannabis retail store located at 1200 Brant Street in […]

Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”) a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the appointment of Eduardo Molinari, a former executive of Abbott Laboratories (NYSE: ABT) (“Abbott”) and AbbVie Ltd. (NYSE: ABBV) (“AbbVie”) as Chief Marketing Officer. Mr. Molinari will […]

WeedMD Inc. (TSX-V: WMD) (OTCQX: WDDMF) (FSE: 4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce it has received a Health Canada Standard Processing Licence (“Processing Licence”) for its 158-acre Strathroy facility. This marks an important step in the Company’s ability to scale up production, packaging and […]

Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”) a Latin American licenced producer of medicinal cannabis and cannabis-derived products, has signed a definitive joint venture agreement (the “Agreement”) with the International Research Center on Cannabis and Mental Health (“IRCCMH” or the “Center”) for the development of medical education programs for […]

WeedMD Inc. (TSX-V: WMD) (OTCQX: WDDMF) (FSE: 4WE), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce it has applied for an amendment to its Strathroy license to expand beyond its existing cultivation with an initial 25-acre, large-scale, low-cost, outdoor cannabis grow operation with the capacity to increase up to 50 acres. […]

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) a leading Colombia based licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has entered into a binding agreement effective March 25, 2019, to acquire cannabis cultivation, processing, manufacturing, export and other rights in Argentina from BBV Labs Inc. Blueberries Medical is […]

Blueberries Medical Corp.(CSE: BBM) (OTC: BBRRF) a Colombia-based licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the appointment of Fabio Valencia Cossio, a former Colombian Minister, Senator and Ambassador to Italy with extensive strategic international business experience to its board of directors. Blueberries Medical is seeking to become a large-scale producer […]

The Children’s Tumor Foundation (CTF) is a foundation dedicated to improving the health and well-being of individuals and families affected by neurofibromatosis (NF). The Foundation is the largest private funder of NF research and works to create the best forms of treatment for sufferers of NF. Annette Bakker, the Children’s Tumor Foundation’s President and Chief […]